Antihypertensive drugs and lip cancer in non-hispanic whites

Archives of Internal Medicine

Volumn 172, Issue 16, 2012, Pages 1246-1251

  Friedman, Gary D ^a,c   Asgari, Maryam M ^a   Warton, E Margaret ^a   Chan, James ^b   Habel, Laurel A ^a  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; LISINOPRIL; NIFEDIPINE;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LIP CANCER; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LIP NEOPLASMS; MALE; MIDDLE AGED; NIFEDIPINE; RISK;

EID: 84866109695     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.2754     Document Type: Article

References (36)

1. Friedman GD, Udaltsova N, Chan J, Quesenberry CP Jr, Habel LA. Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control. 2009;20(10):1821-1835.
2. Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 674-696.
3. Addo HA, Ferguson J, Frain-Bell W. Thiazide-induced photosensitivity: a study of 33 subjects. Br J Dermatol. 1987;116(6):749-760.
4. Quintero B, Miranda MA. Mechanisms of photosensitization induced by drugs: a general survey. Ars Pharmaceutica. 2000;41(1):27-46.
5. Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part II. Cardiol Rev. 2002;10(5):285-300.
6. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703-710.
7. SAS Institute Inc. SAS Online Doc 9.1.2. Cary, NC: SAS Institute Inc; 2004.
8. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:125.
9. Frisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285(13):1736-1745.
10. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59-67.
11. van Leeuwen MT, Grulich AE, McDonald SP, et al. Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev. 2009;18(2):561-569.
12. Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant. 2010;10(8):1889-1896.
13. Elliott MN, Morrison PA, Fremont A, McCaffrey DM, Pantoja P, Lurie N. Using the Census Bureau's surname list to improve estimates of race/ethnicity and associated disparities. Health Serv Outcomes Res Methodol. 2009;9(2):69-83.
14. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. Geneva, Switzerland: World Health Organization; 2000.
15. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. eds. Surveillance, Epidemiology and End Results web site. http://seer.cancer.gov/csr/1975-2007/. Accessed September 10, 2011.
16. Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control. 1996;7(4):458-463.
17. Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis. 1999;5(3):185-195.
18. Gallagher RP, Lee TK, Bajdik CD, Borugian M. Ultraviolet radiation. Chronic Dis Can. 2010;29(suppl 1):51-68.
19. Betka J. Distant metastases from lip and oral cavity cancer. ORL J Otorhinolaryngol Relat Spec. 2001;63(4):217-221.
20. Doll R. Cancers weakly related to smoking. Br Med Bull. 1996;52(1):35-49.
21. Surgeon General. Smoking and Health. Washington, DC: US Dept of Health, Education and Welfare, Public Health Service; 1979:1321-1323.
22. Bross IDJ. Spurious effects from an extraneous variable. J Chronic Dis. 1966;19(6):637-647.
23. Diffey BL, Langtry J. Phototoxic potential of thiazide diuretics in normal subjects. Arch Dermatol. 1989;125(10):1355-1358.
24. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002;25(5):345-372.
25. Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol. 1995;33(4):551-576.
26. Stern RS. Photocarcinogenicity of drugs. Toxicol Lett. 1998;102-103:389-392.
27. Jensen AO, Thomsen HF, Engebjerg MC, Olesen AB, Sørensen HT, Karagas MR. Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study. Br J Cancer. 2008;99(9):1522-1528.
28. Kaae J, Boyd HA, Hansen AV, Wulf HC, Wohlfahrt J, Melbye M. Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(11):2942-2949.
29. Gruber SB, Armstrong BK. Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:1196-1229.
30. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2998-3007.
31. Epstein JH. Phototoxicity and photoallergy. Semin Cutan Med Surg. 1999;18(4):274-284.
32. Lankerani L, Baron ED. Photosensitivity to exogenous agents. J Cutan Med Surg. 2004;8(6):424-431.
33. Roberts JE. Screening for ocular phototoxicity. Int J Toxicol. 2002;21(6):491-500.
34. Mauget-Faÿsse M, Quaranta M, Francoz N, BenEzra D. Incidental retinal phototoxicity associated with ingestion of photosensitizing drugs. Graefes Arch Clin Exp Ophthalmol. 2001;239(7):501-508.
35. Ting WW, Vest CD, Sontheimer R. Practical and experimental consideration of sun protection in dermatology. Int J Dermatol. 2003;42(7):505-513.
36. Institute of Medicine. Report on a population-based policy and systems change approach to prevent and control hypertension. 2010. http://www.iom.edu/ Reports/2010/A-Population-Based-Policy-and-Systems-Change-Approach-to-Prevent- and-Control-Hypertension.aspx. Accessed January 10, 2012.